Evidence map›Paper›PMID 31979089›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against

Lília I L Cabral, Sébastien Pomel, Sandrine Cojean, Patrícia S M Amado, Philippe M Loiseau, Maria L S Cristiano

Abstract readLetter
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Diversified Synthesis ofACS omega · 2024
    Article
  8. Bridged 1,2,4-Trioxolanes: SnClMolecules (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. A clioquinol-containing PluronicParasite (Paris, France) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lília I L CabralCenter of Marine Sciences, CCMAR, Gambelas Campus, University of Algarve, UAlg, 8005-139 Faro, Portugal.
Sébastien PomelChimiothérapie Antiparasitaire, Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France.
Sandrine CojeanChimiothérapie Antiparasitaire, Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France.
Patrícia S M AmadoCenter of Marine Sciences, CCMAR, Gambelas Campus, University of Algarve, UAlg, 8005-139 Faro, Portugal.
Philippe M LoiseauChimiothérapie Antiparasitaire, Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France.
Maria L S CristianoCenter of Marine Sciences, CCMAR, Gambelas Campus, University of Algarve, UAlg, 8005-139 Faro, Portugal.

Funding

Fundação para a Ciência e a Tecnologia PTDC/MAR-BIO/4132/2014Fundação para a Ciência e a Tecnologia SFRH/BD/130407/2017Fundação para a Ciência e a Tecnologia UID/Multi/ 04326/2013
6 · The paper itself

Abstract

A chemically diverse range of novel tetraoxanes was synthesized and evaluated in vitro against intramacrophage amastigote forms of

Indexed as

AnimalsAntiprotozoal AgentsLeishmania donovaniLeishmaniasisMicePhosphorylcholineTetraoxanesAntiprotozoal AgentsmiltefosinePhosphorylcholineTetraoxanesantileishmanial chemotherapyantimalarials re-purposingLeishmaniasisperoxide-derived antimalarialstetraoxanes

Identifiers

PMID31979089
PMCPMC7038143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.